Pharmacogenomics Study of CPT-11 as the First-lineChemotherapy for SCLC.

Trial Profile

Pharmacogenomics Study of CPT-11 as the First-lineChemotherapy for SCLC.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Irinotecan (Primary) ; Antineoplastics; Cisplatin
  • Indications Small cell lung cancer
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 24 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register record.
    • 23 Jan 2013 Planned end date changed from 1 Aug 2013 to 31 Aug 2013 as reported by Chinese Clinical Trial Register record.
    • 05 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top